Panacea Life Sciences Valuation Multiples

Discover revenue and EBITDA valuation multiples for Panacea Life Sciences and similar public comparables like Naples Soap, IMD Companies, Neon Bloom, Green PolkaDot Box and more.

Panacea Life Sciences Overview

About Panacea Life Sciences

Panacea Life Sciences Holdings Inc is a holding company organized as a plant based natural health ingredient and product company, specializing in the development, manufacturing, research, and distribution of products and rapidly growing natural health and wellness market segment for both humans and animals. Its products are CBD Softgels, CBD Tablets, CBD Topicals, CBD Skin Care, CBD Tinctures, CBD Edibles, CBD Patches, CBD Pets, and PPE.


Founded

2008

HQ

United States

Employees

25

Financials (FY)

Revenue: $2M
EBITDA: ($5M)

EV

$2M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Panacea Life Sciences Financials

Panacea Life Sciences reported last fiscal year revenue of $2M and negative EBITDA of ($5M).

In the same fiscal year, Panacea Life Sciences generated $1M in gross profit, ($5M) in EBITDA losses, and had net loss of ($8M).


Panacea Life Sciences P&L

In the most recent fiscal year, Panacea Life Sciences reported revenue of $2M and EBITDA of ($5M).

Panacea Life Sciences is unprofitable as of last fiscal year, with gross margin of 47%, EBITDA margin of (199%), and net margin of (336%).

See analyst estimates for Panacea Life Sciences
Last FY2023202620272028
Revenue$2M$2M
Gross Profit$1M$1M
Gross Margin47%47%
EBITDA($5M)($5M)
EBITDA Margin(199%)(199%)
EBIT Margin(233%)(233%)
Net Profit($8M)($8M)
Net Margin(336%)(336%)
Net Debt$15M-

Financial data powered by Morningstar, Inc.

Panacea Life Sciences Stock Performance

Panacea Life Sciences has current market cap of $2M, and enterprise value of $2M.


Panacea Life Sciences' stock price is $0.09.

Panacea Life Sciences has an EPS (earnings per share) of $-0.38.

See more trading valuation data for Panacea Life Sciences
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2M$2M-11.9%---$-0.38

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Panacea Life Sciences Valuation Multiples

Panacea Life Sciences trades at 0.9x EV/Revenue multiple, and (0.4x) EV/EBITDA.

See NTM and 2027E valuation multiples for Panacea Life Sciences

Panacea Life Sciences Financial Valuation Multiples

As of August 14, 2026, Panacea Life Sciences has market cap of $2M and EV of $2M.

Panacea Life Sciences has a P/E ratio of (0.2x).

Last FY2023202620272028
EV/Revenue0.9x0.9x
EV/EBITDA(0.4x)(0.4x)
EV/EBIT(0.4x)(0.4x)
EV/Gross Profit1.9x1.9x
P/E(0.2x)(0.2x)
EV/FCF(1.3x)(1.3x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Panacea Life Sciences Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Panacea Life Sciences Margins & Growth Rates

In the most recent fiscal year, Panacea Life Sciences reported gross margin of 47%, EBITDA margin of (199%), and net margin of (336%).

See estimated margins and future growth rates for Panacea Life Sciences

Panacea Life Sciences Margins

Last FY202720282029
Gross Margin47%
EBITDA Margin(199%)
EBIT Margin(233%)
Net Margin(336%)
FCF Margin(67%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Panacea Life Sciences Operational KPIs

Panacea Life Sciences' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.3M for the same period.

Access forward-looking KPIs for Panacea Life Sciences
Last FY2023202620272028
Revenue per Employee$0.1M-
Opex per Employee$0.3M-
G&A Expenses to Revenue61%61%
Opex to Revenue280%280%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Panacea Life Sciences Competitors

Panacea Life Sciences competitors include Naples Soap, IMD Companies, Neon Bloom, Green PolkaDot Box, Sunniva, IM Cannabis, Dogecoin Cash, Aion Therapeutic, Pharmadrug and Strainsforpains.

Most Panacea Life Sciences public comparables operate across Cannabis, Health & Beauty, Pet Care, CannaTech, ViceTech and PetTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Naples Soap0.8x-(81.8x)-
IMD Companies----
Neon Bloom----
Green PolkaDot Box----
Sunniva----
IM Cannabis0.3x-(2.2x)-
Dogecoin Cash1.2x-(0.1x)-
Aion Therapeutic11.4x-(0.7x)-

This data is available for Pro users. Sign up to see all Panacea Life Sciences competitors and their valuation data.

Start Free Trial

Panacea Life Sciences VC Funding History

Before going public, Panacea Life Sciences raised $7M in total equity funding, across 1 round.


Panacea Life Sciences Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Dec-19Series A-$7M-Panacea Life Sciences raised $7 million on December 18, 2019, as an initial filing from an offering of $14 million. The company, based in Greenwood Village, Colorado, offers premium CBD topicals, tinctures, and capsules for retail, wholesale, and affiliates. In December 2019, XXII made a $14 million investment consisting of $7 million in preferred stock and $7 million in convertible debt.

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Panacea Life Sciences

When was Panacea Life Sciences founded?Panacea Life Sciences was founded in 2008.
Where is Panacea Life Sciences headquartered?Panacea Life Sciences is headquartered in United States.
How many employees does Panacea Life Sciences have?As of today, Panacea Life Sciences has over 25 employees.
Is Panacea Life Sciences publicly listed?Yes, Panacea Life Sciences is a public company listed on OTCM.
What is the stock symbol of Panacea Life Sciences?Panacea Life Sciences trades under PLSH ticker.
When did Panacea Life Sciences go public?Panacea Life Sciences went public in 2021.
Who are competitors of Panacea Life Sciences?Panacea Life Sciences main competitors include Naples Soap, IMD Companies, Neon Bloom, Green PolkaDot Box, Sunniva, IM Cannabis, Dogecoin Cash, Aion Therapeutic, Pharmadrug, Strainsforpains.
What is the current market cap of Panacea Life Sciences?Panacea Life Sciences' current market cap is $2M.
What is the current revenue of Panacea Life Sciences?Panacea Life Sciences' last fiscal year revenue is $2M.
What is the current EV/Revenue multiple of Panacea Life Sciences?Current revenue multiple of Panacea Life Sciences is 0.9x.
Is Panacea Life Sciences profitable?No, Panacea Life Sciences is not profitable.
How many companies Panacea Life Sciences has acquired to date?Panacea Life Sciences hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Panacea Life Sciences has invested to date?Panacea Life Sciences hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Panacea Life Sciences

Lists including Panacea Life Sciences

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial